Filters

DAZ1 Antibody

DAZ1 Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameDAZ1 Primary Polyclonal Antibody
Also known asDAZ1 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenDAZ1
SpecificityThis is a highly specific antibody against DAZ1
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human DAZ1
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen It may regulate translation of mRNAs by binding to the 3'-UTR, DAZ1 (deleted in azoospermia 1) is an RNA-binding protein that is essential in spermatogenesis
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names DAZ, DAZ1_HUMAN, Deleted in azoospermia, Deleted in azoospermia 1, Deleted in azoospermia protein 1, SPGY, DAZ 1
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetDAZ1
Short nameDAZ1 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameDAZ1 (Antibody to)
Alternative techniqueantibodies
Identity 2682
Gene DAZ1
Long gene name deleted in azoospermia 1
Synonyms gene DAZ
Synonyms gene name deleted in azoospermia
Synonyms SPGY
Locus Yq11, 223
Discovery year 1996-04-12
Entrez gene record 1617
Pubmed identfication 7670487
RefSeq identity NM_004081
Classification RNA binding motif containing
Havana BLAST/BLAT OTTHUMG00000044053

Subscribe to our Newsletter